Category: Pharmaceuticals
Canada Pharmaceuticals
-
Healthcare Logistics Market in Canada 2025-2029
... the healthcare logistics market in canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Pharmaceuticals in Canada: ISIC 2423
... 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key ... Read More
-
Generics in Canada
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Connected Drug Delivery Devices Market by Type of Device (Connected / Smart Wearable Injectors, Connected / Smart Inhalers, Connected / Smart Pen Injectors, Connected / Smart Autoinjectors and Connected / Smart Needle-free Injection Systems), Mode of Connectivity (Bluetooth-enabled Devices, Near Field Communication-enabled Devices, Cellular-enabled Devices and Wide Area Network-enabled Devices), Route of Administration (Parenteral and Inhalational), Therapeutic Area (Metabolic Disorders, Respiratory Disorders, Autoimmune Disorders and Other Disorders), and Geographical Regions ((North America (US and Canada), Europe (UK, Germany, France, Italy, Spain and Rest of the Europe), Asia-Pacific (China, India, Japan and Rest of the Asia-Pacific), Middle East and North Africa (Egypt, Israel, Saudi Arabia, and Rest of the Middle East and North Africa), and Latin America and Rest of the World (Brazil, Argentina and Rest of the World)): Industry Trends and Global Forecasts, Till 2035
... of Connectivity (Bluetooth-enabled Devices, Near Field Communication-enabled Devices, Cellular-enabled Devices and Wide Area Network-enabled Devices), Route of Administration (Parenteral and Inhalational), Therapeutic Area (Metabolic Disorders, Respiratory Disorders, Autoimmune Disorders and Other Disorders), and Geographical Regions ... Read More
-
Pharmaceutical Robots Market in Northern America
... growth patterns, and forecasts spanning the years 2021 to 2029. Gain insights into a comprehensive understanding of the industry landscape. Please note: the online download version of this report is for a global site license. Read More
-
Pharmaceutical Robots Market in Canada
... growth patterns, and forecasts spanning the years 2021 to 2029. Gain insights into a comprehensive understanding of the industry landscape. Please note: the online download version of this report is for a global site license. Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Pharmaceuticals & Pharmacy Supplies Wholesaling in Canada - Industry Market Research Report
... of external competition from manufacturers, which is endemic to most wholesale industries. Pharmaceutical wholesalers and self-distributing pharmacy chains, which are excluded from the industry, account for 95.0% of total pharmaceuticals distributed to pharmacies and to ... Read More
-
Canada Diabetes Devices Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
... Size The Canada Diabetes Device market is expected to reach US$ 736.5 Million in 2023 to US$ 1,384.7 Million by 2032, with a CAGR of 7.27 % from 2024 to 2032. The growing prevalence of ... Read More
-
2024-2029 North America Anemia Diagnostic Testing Market Assessment in Canada, Mexico, US - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... provides information and analysis not available from any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging ... Read More
-
2024-2029 Canada Anemia Diagnostic Testing Market Assessment - 2024 Supplier Shares and 2024-2029 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities
... any other published source, including: Supplier Sales and Shares by Segment and Test Volume and Sales Segment Forecasts by Test Supplier Strategies and SWOT Analysis Instrumentation Pipeline Emerging Technologies Opportunities for New Analyzers and Consumables ... Read More
-
Herbal/Traditional Products in Canada
... wary of the potential effects of using artificial chemicals, especially over the longer term, and turning to more natural alternatives. Herbal/traditional topical analgesics is expected to lead growth, with rising demand primarily being driven by ... Read More
-
Dietary Supplements in Canada
... probiotic supplements recording notable growth underpinned by consumers’ continued interest in gut health and general wellness. There is growing awareness of the role of the gut microbiome in overall health and wellbeing, which is supporting ... Read More
-
NRT Smoking Cessation Aids in Canada
... the related attempts to reduce or quit smoking, which often takes multiple attempts and can involve consumption of multiple products such as patches and gum as consumers look for the most effective solution. Euromonitor’s Voice ... Read More
-
Vitamins in Canada
... the experience of the COVID-19 crisis and in the context of the stress caused by challenging economic conditions and an increase in the cost of living. In general, the health and wellness trend has shifted ... Read More
-
Paediatric Consumer Health in Canada
... as these categories continue to normalise after the massive spike in demand in 2022, which was caused by the flu/RSV/COVID “triple-demic” and led to shortages of such products. In 2024, most regions of Canada saw ... Read More
-
Analgesics in Canada
... previous year as demand began to normalise after the sharp increase in demand for pain relief in 2022 as respiratory syncytial virus (RSV), the flu and COVID-19 circulated amongst Canadians. Consumers bought analgesics in 2023 ... Read More
-
Digestive Remedies in Canada
... consumers have fully transitioned back to workplaces and social events and are looking for on-the-go remedies as they commute to work and social events. They are also looking for motion sickness remedies as travel has ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in Canada
... and cold products are expected to see sales fall in 2024 following a decline in the previous year as consumer demand continued to normalise following the spike in demand for such remedies in 2022, when ... Read More
-
Dermatologicals in Canada
... the drivers that were predominating prior to the outbreak of COVID-19, including Canada’s ageing population, which is helping to drive growth in categories such as haemorrhoid treatments. Older Canadians are more prone to haemorrhoids due ... Read More
-
Sleep Aids in Canada
... Voice of the Consumer: Health and Nutrition Survey showed respondents had increased concern over sleeping problems in 2024, with 10% of respondents being extremely concerned with sleeping problems compared to 8% in 2023, while 35% ... Read More
-
Consumer Health in Canada
... marked by extreme demand and cough, cold and analgesics shortages caused by the “triple-demic” of flu, respiratory syncytial virus (RSV) and COVID-19. Growth is expected despite headwinds from an inflation-driven higher cost of living including ... Read More
-
Pharmaceuticals in Canada
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer ... Read More
-
Mental Health & Substance Abuse Centres in Canada - Industry Market Research Report
... abuse treatment has supported the growth of mental health and substance abuse centres in Canada. Expansion of mental health centres has been crucial, as the country's growing population and rising rates of mental health and ... Read More
Research Assistance
